Sugi Predict

Sugi Predict / Compounds / SCHEMBL30723243

SCHEMBL30723243

SCHEMBL30723243

CCCCCCCCN(C)C(=O)[C@H](O)[C@@H](O)[C@@H](O)CO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 4/20 0.37
▸ DNM1 Q05193 3/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ SPHK1 Q9NYA1 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ THPO P40225 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CETP P11597 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ UBE2N P61088 1/20 0.35
▸ GGPS1 O95749 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31758899 1.00 EPHX2 (0.37) EPHX2DNM1PDE4ACYP2D6KDM4E
SCHEMBL30723269 1.00 EPHX2 (0.37) EPHX2DNM1PDE4ACYP2D6KDM4E
SCHEMBL30723249 0.82 GPR84 (0.42) EPHX2DNM1PDE4AMAPT
SCHEMBL8924940 0.81 PDE4A (0.43) PDE4ACYP2D6KDM4ESPHK1GMNN
SCHEMBL9432507 0.75 DNM1 (0.43) EPHX2DNM1GGPS1MEN1KMT2A
SCHEMBL8369911 0.75 DNM1 (0.43) EPHX2DNM1GGPS1MEN1KMT2A
SCHEMBL7770444 0.75 PDE4A (0.35) PDE4ACYP2D6KDM4ESPHK1GMNN
SCHEMBL7749705 0.75 CA12 (0.40) CYP2D6KDM4ESPHK1GMNNLMNA
SCHEMBL18652130 0.74 PDE4A (0.50) PDE4AKDM4ELMNA
SCHEMBL22891108 0.74 CA1 (0.38) EPHX2DNM1MAPTGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2026-01-08 — — US claimed
EP-4540220-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES Coöperatie Koninklijke Cosun U.A. (NL) 2025-04-23 — — EP claimed
WO-2023242424-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2023-12-21 — — WO claimed
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2026-01-08 — — US disclosed
EP-4540220-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES Coöperatie Koninklijke Cosun U.A. (NL) 2025-04-23 — — EP disclosed
WO-2023242424-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES COÖPERATIE KONINKLIJKE COSUN U.A. (NL) 2023-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008801-A1 BIO-BASED SURFACTANTS DERIVED FROM CARBOHYDRATES CEL, SI, ACMSD EPHX2 3912/4885DNM1 3404/4885PDE4A 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.